Title:
COMBINATION OF LIPOIC ACIDS AND CONJUGATED ACIDS FOR TREATING DIABETIC DISORDERS
Document Type and Number:
WIPO Patent Application WO2002022111
Kind Code:
A3
Abstract:
The invention relates to the use of lipoic acids, or a physiologically acceptable derivative or salt thereof, and a compound of formula (I): H3C-(CH2)n1-(CH=CH)n3-(CH2)n2-COOH - wherein n1 and n2 independently have the value of a whole number from 3 to 9, n3 has the value of a whole number from 2 to 6, and the number of carbon atoms amounts to 18, 20 or 22 - or a physiologically acceptable derivative or salt thereof, as food supplements, in functional foods and for therapeutic purposes in the treatment of diabetic disorders. The invention also relates to agents having a corresponding active ingredient combination and to agents in the form of commercial packs having corresponding combination preparations or monopreparations for combined use.
Inventors:
HASSELWANDER OLIVER (DE)
KRAEMER KLAUS (DE)
BALDENIUS KAI-UWE (DE)
KLATT MARTIN JOCHEN (DE)
SCHWEIKERT LONI (DE)
KRAEMER KLAUS (DE)
BALDENIUS KAI-UWE (DE)
KLATT MARTIN JOCHEN (DE)
SCHWEIKERT LONI (DE)
Application Number:
PCT/EP2001/010501
Publication Date:
February 27, 2003
Filing Date:
September 11, 2001
Export Citation:
Assignee:
BASF AG (DE)
HASSELWANDER OLIVER (DE)
KRAEMER KLAUS (DE)
BALDENIUS KAI-UWE (DE)
KLATT MARTIN JOCHEN (DE)
SCHWEIKERT LONI (DE)
HASSELWANDER OLIVER (DE)
KRAEMER KLAUS (DE)
BALDENIUS KAI-UWE (DE)
KLATT MARTIN JOCHEN (DE)
SCHWEIKERT LONI (DE)
International Classes:
A23L1/30; A61K31/00; A61K31/202; A61K31/385; A61P3/10; A61K31/381; A61P9/10; A61P13/12; A61P25/02; A61P27/02; (IPC1-7): A61K31/385; A23L1/30; A61P3/10
Domestic Patent References:
| WO1999029317A1 | 1999-06-17 |
Foreign References:
| US5948810A | 1999-09-07 |
Download PDF: